In the largest clinical genomic profiling study of non-Hispanic Black men with metastatic prostate cancer to date, ...

As a psychiatrist and president and CEO of Sheppard Pratt, I recognize the importance of understanding the benefits and risks ...

Discover how semaglutide reduces heart attack and stroke risk by 20% in overweight individuals, with benefits appearing ...

PHILADELPHIA, PA — Cabaletta Bio, Inc. (Nasdaq: CABA) has announced key updates on its RESET-Myositis trial and plans for the ...